Daklinza and Zoloft drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Daklinza (daclatasvir dihydrochloride) and Zoloft (sertraline hydrochloride). Common drug interactions include death among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Daklinza and Zoloft. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Daklinza?
Daklinza has active ingredients of daclatasvir dihydrochloride. eHealthMe is studying from 3,312 Daklinza users. Check the latest studies of Daklinza.
What is Zoloft?
Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.
17 people who take Daklinza and Zoloft together, and have interactions are studied.

What are the common drug interactions of Daklinza and Zoloft, by gender? *:
female:
- Death
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
- Pain
- Pain in extremity
- Pruritus (severe itching of the skin)
- Rash
- Retroperitoneal abscess (a collection of pus between the peritoneum and the posterior abdominal wall. retroperitoneal. behind the peritoneum)
- Sepsis (a severe blood infection that can lead to organ failure and death)
male:
- Fatigue (feeling of tiredness)
- Pneumonia
- Death
- Dehydration (dryness resulting from the removal of water)
- Hepatitis c
- Hypertension (high blood pressure)
- Hypoaesthesia (reduced sense of touch or sensation)
- Lactic acidosis (low ph in body tissues)
- Loss of consciousness
- Memory impairment
What are the common drug interactions of Daklinza and Zoloft, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Headache (pain in head)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Pain
- Pain in extremity
- Pruritus (severe itching of the skin)
- Rash
30-39:
- Asthenia (weakness)
- Death
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Loss of consciousness
- Memory impairment
- Migraine (headache)
- Visual impairment
40-49:
- Hepatitis c
- Pneumonia
- Abdominal distension
- Abdominal pain lower
- Psychotic disorder
- Fatigue (feeling of tiredness)
50-59:
- Death
- Retroperitoneal abscess (a collection of pus between the peritoneum and the posterior abdominal wall. retroperitoneal. behind the peritoneum)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Fatigue (feeling of tiredness)
- Lactic acidosis (low ph in body tissues)
60+:
n/a
What are the existing conditions these people have? *
- Hepatitis C: 12 people, 70.59%
- Stress And Anxiety: 1 person, 5.88%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.88%
- Seasonal Allergy (allergic condition due to certain season): 1 person, 5.88%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 5.88%
- Insomnia (sleeplessness): 1 person, 5.88%
- Diabetes: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Daklinza and Zoloft?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Daklinza and Zoloft:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Daklinza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zoloft:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Daklinza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoloft and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
- Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on daclatasvir dihydrochloride and sertraline hydrochloride (the active ingredients of Daklinza and Zoloft, respectively), and Daklinza and Zoloft (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Atenolol and Prednisolone - a second ago
- Abilify and Osteoarthritis for Women aged 50-59 - a second ago
- Abilify and Osteoarthrosis for Women aged 50-59 - 2 seconds ago
- Could Vitamin D cause Extradural Abscess? - 2 seconds ago
- Abilify and Hypertrophic Osteoarthritis for Women aged 50-59 - 2 seconds ago
- Abilify and Djd for Women aged 50-59 - 2 seconds ago
- Abilify and Degenerative Joint Disease for Women aged 50-59 - 2 seconds ago
- Abilify and Arthritis - Osteoarthritis for Women aged 50-59 - 3 seconds ago
- Abilify and Oa for Women aged 50-59 - 3 seconds ago
- Drug interactions of Prezista and Juluca - 9 seconds ago